Web Analytics
ICCC (NASDAQ) Stock Analysis | IMMUCELL CORPORATION – Deepscope
MARKET

Select Market Data Region

ICCC — IMMUCELL CORPORATION (Healthcare >> Biotechnology)

ICCC FAQ

What is ICCC's P/E ratio?

IMMUCELL CORPORATION (ICCC) currently trades at a P/E ratio of 35.58.

What is ICCC's ROE?

IMMUCELL CORPORATION reports a Return on Equity (ROE) of -1.87%.

What is ICCC's dividend yield?

IMMUCELL CORPORATION offers a dividend yield of 0.00%.

What is ICCC's Deepscope Quality Score?

Deepscope rates ICCC's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ICCC?

Deepscope's AI Timing Score for ICCC is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ICCC belong to?

IMMUCELL CORPORATION is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-08 | FS: 2026-03-31)

ICCC

IMMUCELL CORPORATION
USD 9.70
0.09 (0.94%) Day Change
35.58
P/E
0.30
D/E
-1.9%
ROE
-1.2%
ROA
0.00%
Div Yield
10.14
PEG
USD 9.70
Price
0.09 (0.94%)
Day Change
NEWS SCORE: 99

ICCC, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors 42%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 9.70
  PBV / Sector
2.98 / 4.75
  Earning Per Share -0.06
  PE / Sector
35.58 / 17.65
  PEG or PE/Growth / Sector
10.14 / 0.52
  Average 1M Daily Value
0.31 M
GREAT
  Average 1W Daily Value
0.19 M
GREAT
Timing Factors 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 56%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-1.82 / 468.85
  NPM Average (%) / Sector
-12.04 / -1,531.69
  NPM Change Average (%) / Sector
-8.66 / 5,028.65
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-1.24 / 31.69
  ROA Average (%) / Sector
-5.44 / -353.18
  ROA Change Average (%) / Sector
-6.23 / 5,214.65
  ROE (%) / Sector
-1.87 / 10.58
  ROE Average (%) / Sector
-8.97 / 27.64
  ROE Change Average (%) / Sector
3.28 / 2,048.88
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 3.97
Registration Details
X
  Analyze Date 2026-06-09 09:40:00
  Symbol ICCC
  Name IMMUCELL CORPORATION
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 9.05 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 86.94 / 9,000.42
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 56 Evergreen Drive, Portland, ME, United States, 04103

Phone: 207 878 2770

Website: https://immucell.com

Employees: 73

Sector: Healthcare >> Biotechnology

Description: ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.

ME vs SECTOR Healthcare >> Biotechnology

ICCC (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
ICCC
ICCC
USD 9.70 (0.94%)
+ Watch + Port Chart